Evidence mapPaperPMID 41701712Full record

ArticlePLOS digital health2026

Narrowing the A1c gap: Personalized modeling of HbA1c- continuous glucose monitor discordance in type 1 diabetes.

Simon Lebech Cichosz, Camilla Heisel Nyholm Thomsen, David C Klonoff, Irl B Hirsch, Morten Hasselstrøm Jensen

Abstract read
In one paragraph

Article in PLOS digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Simon Lebech CichoszDepartment of Health Science and Technology, Aalborg University, Denmark.ORCID https://orcid.org/0000-0002-3484-7571
Camilla Heisel Nyholm ThomsenDepartment of Health Science and Technology, Aalborg University, Denmark.ORCID https://orcid.org/0000-0001-6229-7282
David C KlonoffDiabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, California, United States of America.
Irl B HirschDivision of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, Washington, United States of America.
Morten Hasselstrøm JensenDepartment of Health Science and Technology, Aalborg University, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aims to characterize the temporal discordance between CGM-derived glucose exposure and HbA1c over time in individuals with type 1 diabetes, and to explore the development of a statistical model to adjust the relationship between these measures based on previously observed individual discrepancies. We paired CGM-data in a 60-day window prior to each HbA1c measurement and included individuals with type 1 diabetes with multiple pairs to assess and model discordance over time. Discordance was defined as difference between HbA1c and Glucose Management Indicator at each pair. At baseline (first pair), participants were categorized into three groups based on the degree of discordance: positive (≥0.5%), negative (≤-0.5%), and neutral (within ±0.5%). A multiple linear regression model incorporating historical discordance values, HbA1c levels, and the current GMI was utilized for an adjustment. 477 individuals were included and 1,523 instances of paired HbA1c and CGM-data were analyzed. Absolute discordance of ≥0.5% was observed in 31% of cases. In 51% of instances, the direction of discordance in each pair was maintained. In the modeling analysis, GMI accounted for 69% of the variance in HbA1c levels (r = 0.83, p < 0.001, MAE = 0.42%). Adjusting improved variance explainability to 82% (r = 0.90, p < 0.001, MAE = 0.33%). HbA1c-CGM discordance is highly prevalent, and while inter-individual discordance shows some degree of persistence, it also appears to vary over time for a substantial proportion of individuals. Adjusting for individual discordance in the short term can improve the alignment between adjusted GMI and laboratory-measured HbA1c.

Identifiers

PMID41701712
PMCPMC12912621

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.